Tuesday, September 26, 2023 |

Md. bio Adaptive Phage Therapeutics cutting 23% of staff to focus on clinical trials, extend cash runway

March 15, 2023

Gaithersburg’s Adaptive Phage Therapeutics Inc. is laying off a chunk of its workforce to devote more resources to its clinical trials and bank more cash, co-founder and CEO Greg Merril told the Washington Business Journal. The biotech, whose therapy targets drug-resistant bacteria, intends to eliminate 22 positions — 23% of its staff — to bring its headcount to 72.

Article Source: Washington Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.